Given the recent pooled analysis of STARS and ROSEL trials, can we say SBRT for early stage NSCLC is equivalent to lobectomy based on level 1 evidence?  

We still do not have Level I evidence to answer such a question. Both STARS and ROSEL closed prematurely. If we read @Joe Y. Chang's Lancet Oncology paper more carefully, unlike others who have interpreted it as radiation oncologists running amock to claim SBRT is now equivalent to surgery, the disu...

It is still too early to state that SBRT should replace lobectomy as a standard treatment for operable stage I NSCLC due to small case number in this randomized study. However, SBRT should be considered as a treatment option for operable stage I NSCLC. We will continue to push NCCN guidelines as mo...